Home » Topics » BioWorld Science

BioWorld Science
RSS

New Rho kinase inhibitors described by Chiesi Farmaceutici

Aug. 21, 2018

Hanmi Science patents oncolytic compounds

Aug. 21, 2018

Vectura completes pediatric studies with VR-647 for asthma

Aug. 21, 2018

Antiangiogenic compounds synthesized at Celgene

Aug. 21, 2018

Adare Pharmaceuticals describes cysteamine prodrugs

Aug. 21, 2018

Biogen identifies new NRF2 activators

Aug. 21, 2018

Phase III study of MC2-01 cream in psoriasis vulgaris meets primary and secondary endpoints

Aug. 21, 2018

Novo Nordisk reports topline PIONEER 5 results for oral semaglutide

Aug. 21, 2018

Chugai's describes candidate for the treatment of hyperphosphatemia EOS-798

Aug. 21, 2018

New oral selective apelin agonist AM-2995 developed for heart disease treatment

Aug. 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...